Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
Study NCT ID:
NCT06109558
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2023-10-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
Sponsor:
Hunan Province Tumor Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-25
First Submit QC Date:
None
Study First Post Date:
2023-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-28
Last Update Post Date:
2024-05-30
Last Update Post Date Type:
ACTUAL